Confident Investing Starts With TipRanks Premium

Get 55% Off
TipRanks
Go Ultimate55% OFF

Amoeba SA (A1H) Stock Price & Analysis

A1H Stock Chart & Stats

€0.26-€0.01(-1.92%)
At close: 5:30 PM GMT+1
EUR 0.5EUR 0.7517 Jul7 Sep9 Sep25 Sep
Day’s Range
EUR 0.26 - EUR 0.26
52-Week Range
EUR 0.26 - EUR 1.09
Previous Close
EUR 0.26
Volume
0
Average Volume (3M)
2,564
Market Cap
EUR 33.06M
Enterprise Value
EUR 78.49M
Total Cash (Recent Filing)
EUR 4.72M
Total Debt (Recent Filing)
EUR 12.24M
Price to Earnings (P/E)
―
Beta
0.58
Next Earnings
Apr 01, 2027 (Est.)
EPS Estimate
N/A
Next Dividend Ex-Date
N/A
Dividend Yield
N/A

Bulls Say, Bears Say

Bulls Say

Proprietary Bio-based Platform

The proprietary amoeba-based platform gives Amoéba a defined technology foundation spanning biocontrol, crop protection and industrial applications. If regulatory development and commercialization progress, the same underlying platform could support multiple products and markets over time.

Losses Narrowed

Narrower operating and net losses indicate some improvement in cost absorption or spending control compared with the earlier period. Although profitability remains deeply negative, continued progress could extend the company’s runway and improve the economics of future commercialization.

Improving Free Cash Flow Trend

The improvement in free cash flow from prior lows is a constructive directional signal for the business. It suggests cash consumption may be moderating, which could reduce funding pressure if the trend persists, even though cash generation remains negative overall.

Bears Say

Revenue Collapse

Revenue collapsing to zero shows that the company has not yet established dependable commercial scale. Without recurring sales, fixed research, regulatory and operating costs remain difficult to cover, leaving future performance highly dependent on successful product commercialization.

Persistent Cash Burn

Sustained negative operating and free cash flow means the business is not funding its activities internally. Continued cash burn can force reliance on external financing, limit investment flexibility, and increase the risk that development timelines are constrained by available capital.

Negative Equity And Rising Debt

Negative equity combined with materially higher debt weakens financial resilience and reduces room to absorb setbacks. The resulting refinancing and funding pressure may restrict strategic choices, particularly while revenue is absent and losses continue.

Amoeba SA News

A1H FAQ

What was Amoeba SA’s price range in the past 12 months?
Amoeba SA lowest stock price was €0.26 and its highest was €1.09 in the past 12 months.
What is Amoeba SA’s market cap?
Amoeba SA’s market cap is €33.06M.
When is Amoeba SA’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Amoeba SA’s earnings last quarter?
Amoeba SA released its earnings results on Sep 24, 2026. The company reported -€0.095 earnings per share for the quarter.
Is Amoeba SA overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does Amoeba SA pay dividends?
Amoeba SA does not currently pay dividends.
What is Amoeba SA’s EPS estimate?
Amoeba SA’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Amoeba SA have?
Amoeba SA has 129,179,120 shares outstanding.
What happened to Amoeba SA’s price movement after its last earnings report?
Amoeba SA reported an EPS of -€0.095 in its last earnings report. Following the earnings report the stock price went down -1.245%.
Which hedge fund is a major shareholder of Amoeba SA?
Currently, no hedge funds are holding shares in DE:A1H
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology